Annals of Oncology Advance Access published online on May 25, 2006
Annals of Oncology, doi:10.1093/annonc/mdl096
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Milan and Department of Medicine and Medical Specialties, IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan, Italy
* To whom correspondence should be addressed. Background: The risk of non-Hodgkin's lymphoma (NHL) seems to be enhanced by cigarette smoking and lowered by alcohol drinking. Patients and methods: To assess whether cigarette smoking and alcohol drinking affect NHL survival, a population-based prospective study on 1138 Italian patients, diagnosed in 1991-1993, followed-up until 2002, was carried out. At diagnosis, clinical and socio-demographic data were recorded and lifestyle habits were assessed through a validated questionnaire. Survival analysis was performed with Kaplan-Meier methods. Hazard ratios (HR) were estimated by Cox regression. Results: The mean follow-up was 6.6 years (standard deviation (SD) 4.3). The mean survival time was 7.56 years (SD 0.155). At both univariate and multivariate analysis heavy cigarette smoking and alcohol drinking were associated with poor survival. Compared with those with a lower cumulative exposure to tobacco smoking, those who had smoked >31 pack-years had a worse survival (HR = 1.60, 95%CI = 1.18-2.18). Drinkers had a higher risk of death compared with non-drinkers (HR = 1.41, 95%CI = 1.10-1.81). Considering only those who had NHL as cause of death, the HR for the higher category of pack-years smoked, compared with the lowest, was 1.63 (95% CI = 1.15-2.33) and for drinkers, compared with non-drinkers, it was 1.33 (95% CI = 1.01-1.80). Conclusions: cigarette smoking and alcohol drinking may influence NHL survival.
Received January 29, 2006
Revised March 17, 2006
Accepted March 28, 2006
original article
Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin's lymphoma: a population-based study
T. Battaglioli 1 *,
G. Gorini 2,
A. Seniori Costantini 2,
P. Crosignani 3,
L. Miligi 2,
O. Nanni 4,
E. Stagnaro 5,
R. Tumino 6,
and
P. Vineis 7
2 Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Florence, Italy
3 Epidemiology Unit, National Cancer Institute, Milan, Italy
4 Unit of Biostatistics and Clinical Trials, Romagnolo Oncogic Institute, Forlì, Italy
5 Environmental Epidemiology and Biostatistics Unit, National Cancer Research Institute, Genoa, Italy
6 Cancer Registry, Ragusa Hospital, Ragusa, Italy
7 Cancer Epidemiology Unit, University of Turin, Turin, Italy; Department of Epidemiology and Public Health, Imperial College, London, UK
T. Battaglioli, E-mail: tullia.battaglioli{at}unimi.it
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?